Literature DB >> 2008438

Lymphocyte-homing receptors and preferential migration pathways.

Y H Chin1, R Sackstein, J P Cai.   

Abstract

Over the next few years, research can be expected to focus on the regulation of expression of the tissue-specific homing receptors, the molecular nature of the corresponding endothelial ligands, and the spectrum of factors regulating the adhesiveness of high endothelial venule cells in vivo. In addition, it would be important to elucidate whether other adhesion molecules also play a role in tissue-specific lymphocyte entry and localization into distinct regions of the lymphoid organ. The results of these studies should provide important insights into the mechanisms controlling lymphocyte trafficking into lymphoid tissues as well as chronic inflammatory sites.

Mesh:

Substances:

Year:  1991        PMID: 2008438     DOI: 10.3181/00379727-196-43201a

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  5 in total

Review 1.  Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration.

Authors:  Robert Sackstein
Journal:  Ann Biomed Eng       Date:  2011-11-09       Impact factor: 3.934

2.  Dynamic alterations in chemokine gradients induce transendothelial shuttling of human T cells under physiologic shear conditions.

Authors:  Jack Y Lee; Catherine D Buzney; Mark C Poznansky; Robert Sackstein
Journal:  J Leukoc Biol       Date:  2009-12       Impact factor: 4.962

3.  Tissue-specific homing receptor mediates lymphocyte adhesion to cytokine-stimulated lymph node high endothelial venule cells.

Authors:  Y H Chin; J P Cai; X M Xu
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

Review 4.  Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology.

Authors:  Robert Sackstein
Journal:  Glycobiology       Date:  2016-02-29       Impact factor: 4.313

5.  Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin.

Authors:  O J de Boer; I M Wakelkamp; S T Pals; N Claessen; J D Bos; P K Das
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.